SHA:688192 Revenue

In the year 2025, Dizal (Jiangsu) Pharmaceutical had annual revenue of 801.14M CNY with 122.60% growth. Dizal (Jiangsu) Pharmaceutical had revenue of 214.83M in the quarter ending December 31, 2025, with 901.58% growth.

Revenue

801.14M

Revenue Growth

+122.60%

P/S Ratio

32.38

Revenue / Employee

793.99K

Employees

1,009

Market Cap

25.94B

Revenue Chart

Revenue History

Fiscal Year End	Revenue	Change	Growth
Dec 31, 2025	801.14M	441.23M	122.60%
Dec 31, 2024	359.90M	268.61M	294.24%
Dec 31, 2023	91.29M	-	-
Dec 31, 2022	-	-	-
Dec 31, 2021	10.29M	-17.48M	-62.95%
Dec 31, 2020	Pro	Pro	Pro
Dec 31, 2019	Pro	Pro	Pro
Dec 31, 2018	Pro	Pro	Pro

Revenue Definition

Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.

Full Definition

Related Stocks

Company Name	Revenue
Livzon Pharmaceutical Group	11.71B
Tianjin Pharmaceutical Da Ren Tang Group Corporation	4.92B
Hubei Jumpcan Pharmaceutical	5.90B
Shijiazhuang Yiling Pharmaceutical	6.01B
Kangmei Pharmaceutical	5.25B
Chengdu Kanghong Pharmaceutical Group	4.43B
Zhejiang Huahai Pharmaceutical	8.71B
Tonghua Golden-Horse Pharmaceutical Industry Co,Ltd	1.17B

Revenue Rankings